GLTO: Galecto, Inc. Stock

by  •  • Comments Off on GLTO: Galecto, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.15
Enterprise Value ($M) -9.67
Book Value ($M) 15.83
Book Value / Share 11.97
Price / Book 0.20
NCAV ($M) 15.54
NCAV / Share 11.75
Price / NCAV 0.20

Profitability (mra)
Return on Invested Capital (ROIC) -1.35
Return on Assets (ROA) -0.66
Return on Equity (ROE) -0.76

Liquidity (mrq)
Quick Ratio 14.07
Current Ratio 14.07

Balance Sheet (mrq) ($M)
Current Assets 16.84
Assets 17.13
Liabilities 1.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -16.90
Net Income -21.44

Cash Flow Statement (mra) ($M)
Cash From Operations -18.62
Cash from Investing 11.65
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-07 13G/A Sunstone Life Science Ventures A/S 2.40
08-29 13G/A Otto Erik 0.00 -100.00
06-24 13D/A Novo Holdings A/S 9.20 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-04-29 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 925 4,247 21.78
2025-04-16 1,697 11,445 14.83
2025-04-15 659 7,883 8.36

(click for more detail)

Similar Companies
GELS – Gelteq Limited GLMD – Galmed Pharmaceuticals Ltd.
GLSI – Greenwich LifeSciences, Inc. GLYC – GlycoMimetics, Inc.
GNLX – Genelux Corporation


Financial data and stock pages provided by
Fintel.io